Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
237
-
Total 13F shares, excl. options
-
49,126,671
-
Shares change
-
+2,702,018
-
Total reported value, excl. options
-
$5,160,489,255
-
Value change
-
+$295,046,604
-
Put/Call ratio
-
50%
-
Number of buys
-
140
-
Number of sells
-
-82
-
Price
-
$105.05
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q2 2017
283 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q2 2017.
BLUEBIRD BIO INC - COM (BLUE) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,126,671 shares
.
Largest 10 shareholders include FMR LLC (6,713,949 shares), Capital Research Global Investors (5,483,117 shares), BAILLIE GIFFORD & CO (5,400,658 shares), WELLINGTON MANAGEMENT GROUP LLP (3,734,843 shares), VANGUARD GROUP INC (3,559,102 shares), BlackRock Inc. (3,320,329 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,918,472 shares), STATE STREET CORP (1,456,088 shares), Capital World Investors (1,106,255 shares), and VICTORY CAPITAL MANAGEMENT INC (983,271 shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.